GSK, Johnson & Johnson Invest in $200m Venture Fund

Mar 22, 2012, 01:20 AM by Michael Croft

NJ.com | GlaxoSmithKline and Johnson & Johnson are forming a $200 million fund to invest in early-stage biotech companies.

March 23, 2012 | GlaxoSmithKline and Johnson & Johnson are forming a $200 million fund to invest in early-stage biotech companies. Each pharma will contribute $50 million while Index Ventures will contribute $100 million. NJ.com